The SeriousTraders Newsletter If you are Serious about Trading, become a SeriousTrader!™

Clene Inc. (NASDAQ: CLNN)

Investment Considerations Demonstrated prolonged life with 59% decreased risk of death in an integrated meta-analysis across the HEALEY ALS Platform Trial and RESCUE-ALS Trial with CNM-AU8 30 mg dose compared to PRO-ACT matched placebo over long-term follow-up (p=.004) 19.3 month survival difference for CNM-Au8 ALS treated participants versus placebo in RESCUE-ALS Trial Multiple near-term milestones, … Continue reading “Clene Inc. (NASDAQ: CLNN)”

View Profile